Evidence map›Paper›PMID 42710667›Full record

ArticleThe Journal of biological chemistry2026

Monomeric C-reactive protein potentiates microglia-mediated neuroinflammation in Alzheimer's disease via the PLC-PKC-MAPK-NF-κB pathway.

Jie Zhang, Yiyi Zhu, Qishan Zhang, Yuting Dai, Hang Liu, Jingming Shi, Yanghua Jiang, Qian Chen

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jie ZhangThe Key Laboratory for High Altitude Brain Injury and Repair, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi Province, China.
Yiyi ZhuThe Key Laboratory for High Altitude Brain Injury and Repair, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi Province, China.
Qishan ZhangDepartment of Neurology, The First People's Hospital of Chenzhou City, Chenzhou, Hunan Province, China.
Yuting DaiThe Key Laboratory for High Altitude Brain Injury and Repair, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi Province, China.
Hang LiuThe Key Laboratory for High Altitude Brain Injury and Repair, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi Province, China.
Jingming ShiThe Key Laboratory for High Altitude Brain Injury and Repair, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi Province, China. Electronic address: shijingming5272@126.com.
Yanghua JiangLaboratory Medical Center of the First People's Hospital of Chenzhou City, Chenzhou, Hunan Province, China. Electronic address: jiangyanghua1225@126.com.
Qian ChenThe Key Laboratory for High Altitude Brain Injury and Repair, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi Province, China. Electronic address: chenqianxj666@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroinflammation is a major contributor to the pathogenesis of Alzheimer's disease (AD). Although elevated serum C-reactive protein (CRP) is associated with increased AD risk, the specific conformational forms of CRP operative in the brain and their underlying mechanisms remain unclear. Here, we combined human brain transcriptomic analysis, APP/PS1 mice studies, and functional assays in BV2 cells and primary microglia to elucidate the roles of Monomeric C-reactive protein (mCRP) in AD-related neuroinflammation. CRP was significantly upregulated in the brains of AD patients and in the hippocampus of APP/PS1 mice, where it extensively colocalized with activated microglia. mCRP directly induced M1 proinflammatory microglial polarization and synergistically enhanced neuroinflammation with amyloid-β

Indexed as

Alzheimer's disease(AD)microgliamonomeric C-reactive protein (mCRP)neuroinflammationPLC/PKC/MAPK/NF-κB signaling pathway

Identifiers

PMID42710667
PMCPMC13671087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.